Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

GEOSPACE TECHNOLOGIES CORP (GEOS)

  • Business News
  • Aug. 06, 2026, 21:45 UTC
  • 1
  • 1 comments

Geospace Technologies Reports Third Quarter and Nine-Months 2026 Results

Market reaction Comment Full text

JOHN HANCOCK FINANCIAL OPPORTUNITIES FUND (BTO)

  • Business News
  • Aug. 06, 2026, 21:45 UTC
  • 1
  • 1 comments

B2Gold Reports Q2 2026 Results; Strong Operating Performance at the Fekola, Masbate, and Otjikoto Mines led to Higher than Expected Gold Production and Lower than Expected All-In Sustaining Costs; Menankoto Exploitation Permit Expected to be Issued in the Near-Term by the State of Mali

Market reaction Comment Full text

ALLEGIANT TRAVEL CO (ALGT)

  • Business News
  • Aug. 06, 2026, 21:45 UTC
  • 1
  • 1 comments

Allegiant Airline Credit Card and Frequent Flyer Program Extend Years-Long Winning Streak in USA TODAYs Readers Choice Awards

Market reaction Comment Full text

ADMA BIOLOGICS, INC. (ADMA)

  • Business News
  • Aug. 06, 2026, 21:42 UTC
  • 1
  • 1 comments

ADMA Biologics, Inc. Deadline: ADMA Investors with Losses in Excess of $100K Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

Market reaction Comment Full text

GLOBE LIFE INC. (GL)

  • Business News
  • Aug. 06, 2026, 21:39 UTC
  • 1
  • 1 comments

GLOBE LIFE INC. DECLARES DIVIDEND

Market reaction Comment Full text

BIOSTEM TECHNOLOGIES, INC. (BSEM)

  • Business News
  • Aug. 06, 2026, 21:38 UTC
  • 1
  • 1 comments

BioStem Technologies Announces Nasdaq Uplisting

Market reaction Comment Full text

GOLDMAN SACHS BDC, INC. (GSBD)

  • Business News
  • Aug. 06, 2026, 21:36 UTC
  • 1
  • 1 comments

Goldman Sachs BDC, Inc. Reports June 30, 2026 Financial Results and Announces Third Quarterly 2026 Base Dividend of $0.32 Per Share and Second Quarter Supplemental Dividend of $0.03 Per Share.

Market reaction Comment Full text

ROYAL CARIBBEAN CRUISES LTD (RCL)

  • Business News
  • Aug. 06, 2026, 21:28 UTC
  • 1
  • 1 comments

Royal Caribbean Group announces pricing of $1.25 billion senior unsecured notes due 2034

Market reaction Comment Full text

WISE GROUP PLC (WSE)

  • Business News
  • Aug. 06, 2026, 21:25 UTC
  • 1
  • 1 comments

WSE Investors Have Opportunity to Lead Wise Group plc Securities Fraud Lawsuit Filed by The Rosen Law Firm

Market reaction Comment Full text

DESTINATION XL GROUP, INC. (DXLG)

  • Business News
  • Aug. 06, 2026, 21:20 UTC
  • 1
  • 1 comments

Destination XL Group, Inc. Appoints Current Chairman Lionel Conacher as Interim Chief Executive Officer

Market reaction Comment Full text

COMSTOCK HOLDING COMPANIES, INC. (CHCI)

  • Business News
  • Aug. 06, 2026, 21:15 UTC
  • 0
  • 1 comments

Comstock Welcomes Bobby's Bagel Café to Loudoun Station

Market reaction Comment Full text

TRANSCONTINENTAL REALTY INVESTORS INC (TCI)

  • Business News
  • Aug. 06, 2026, 21:15 UTC
  • 0
  • 1 comments

Transcontinental Realty Investors, Inc. Reports Earnings for Quarter Ended June 30, 2026

Market reaction Comment Full text

INCOME OPPORTUNITY REALTY INVESTORS INC /TX/ (IOR)

  • Business News
  • Aug. 06, 2026, 21:15 UTC
  • 0
  • 1 comments

Income Opportunity Realty Investors, Inc. reports Earnings for Quarter Ended June 30, 2026

Market reaction Comment Full text

VALHI INC /DE/ (VHI)

  • Business News
  • Aug. 06, 2026, 21:15 UTC
  • 0
  • 1 comments

VitalHub Announces Normal Course Issuer Bid

Market reaction Comment Full text

LEMAITRE VASCULAR INC (LMAT)

  • Business News
  • Aug. 06, 2026, 21:15 UTC
  • 0
  • 1 comments

LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

Market reaction Comment Full text
  • Previous
  • 163
  • 164
  • 165
  • 166
  • 167
  • Next

Search

News categories

  • Technical Exchange News(14168)
  • Event(6229)
  • SEC News(361397)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(222263)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin